- Expect a 'Square Root-Shaped' Recovery: Chief Investor
- HP to Feed on Enterprise Spending Next Year: Tech Analyst
- How Stock Investors Can Play Holiday Travel
- 3 Growth Opportunities in Tech: Analyst
- Prep Your Portfolio for Next Week: Stock Pickers
- Global Growth Good for Portfolio: Stock Picker
- Expect Tech Sector to Rise in Q4: Strategist
- Expect a 5-10% Market Pullback: Stock Picker
- 3 Stock Picks for This Volatile Environment: Portfolio Manager
- 3 Financial Stocks May Lead Final Rally: Market Researcher
MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- Existing-Home Sales Jump To Highest Level in 2-1/2 Years
- Wave of Debt Payments Facing US Government
- Start-Up Proves Everything Really Is Better With Bacon
- TV Retailer QVC Joins `Black Friday' Frenzy
- S&P Stocks Trading at New 52-Week Highs
- China Asks Its Banks to Slow Down
- Paul: Audit the Fed
- Are Crazy Retail Deals Good for Business?
- Expect a 'Square Root-Shaped' Recovery: Chief Investor
- Madoff—The Holiday Drink
- HP to Feed on Enterprise Spending Next Year: Tech Analyst
- Busch: Markets Smell a Country Rat
- Schork Oil Outlook: Mission Impossible For The Bears?
- S&P Stocks Trading at New 52-Week Highs
- Losey: Asset Allocation At Retirement
- Farrell: Obama Hectored, Ignored and Restricted?
- Existing-Home Sales Jump to 2-1/2 Year High
- Wave of Debt Payments Facing US Government
- US Job Losses to Bottom out Next Quarter: NABE
- Obama Jobs Forum May Be More Political Than Practical
- Maria Blog: Are Crazy Retail Deals Good for Business?
- Suze Orman’s 'A Healthier, Wealthier You'
- Latest Holiday Drinks: The Madoff...and the TARPatini
- Madoff Trustee, Law Firm Submit $22.1 Million Bill
- JPMorgan's Dimon Could Succeed Geithner: Report
RSS FEED
CNBC Stock Blog
Text Size 
This is not your garden-variety recession, and Ken Kam of Marketocracy Masters 100 says it means the market of the future will be a lot different from the market of the past.
"The market has fundamentally changed," he told CNBC. "A lot of people who are holding onto stocks, hoping that when things get back to normal that their stocks will get back to even, I think are going to be surprised."
He sees new sectors leading the market when it does come back. So what sectors is he talking about, and whose stocks does he like in those sectors?
Recommendations:
Start with health care, and DepoMed [DEPO
Loading...
()
], a name not often mentioned.
"DepoMed is a small-cap biotech stock," he said. "Biotech and pharmaceuticals are bright spots, because pharmaceuticals have very strong cash flow, so of all industries they have the least need for bank financing."
Kam concedes the sector, too, must change, as patented products go generic, and he sees DepoMed as a prime candidate for acquisition, in a consolidation wave that just saw Pfizer [PFE
Loading...
()
] acquire Wyeth [WYE
Loading...
()
].
"I woult put Cephalon [CEPH
Loading...
()
] in the same category," he added.
He also likes Novo Nordisk [NOVO
Loading...
()
].
Disclosures:
Disclosure information for Ken Kam was not immediately available.
Data is a real-time snapshot *Data is delayed at least 15 minutes